Quest Mobile™ has 5,000 trained mobile phlebotomists whose reach will extend to 44 states by the end of 2023 SECAUCUS, N.J., Nov. 9, 2023 /PRNewswire/ -- Quest Diagnostics (DGX), the nation's leading ...
(RTTNews) - Quest Diagnostics (DGX), a diagnostic services provider, announced Wednesday a new FDA-cleared human papillomavirus (HPV) self-collection solution aimed at broadening access to HPV ...
Mitchell is an associate professor at the University of Virginia and an NIH-funded nurse scientist. Kueter, a former health journalist and public radio reporter, works as a magazine editor at UVA ...
The FDA has cleared its first at-home collection kit that allows women to screen themselves for human papillomavirus and cervical cancer risk by mailing a sample to a lab—where it is analyzed by the ...
Share on Pinterest The FDA has approved the “Teal Wand,” the first-ever self-collection test to screen for cervical cancer. Anchiy/Getty Images The FDA approved the first at-home self-collection test ...
In an effort to combat the prevalence of cervical cancer in the United States, the Food and Drug Administration has approved the first ever at-home cervical cancer screening kit. On Friday, May 9, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results